| scholarly article | Q13442814 |
| P50 | author | Michael A. Laflamme | Q39673791 |
| P2093 | author name string | Hans Reinecke | |
| Elina Minami | |||
| Wei-Zhong Zhu | |||
| P2860 | cites work | Regenerating the heart | Q22251075 |
| MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex | Q24563497 | ||
| Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart | Q24606117 | ||
| Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells | Q24616059 | ||
| Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells | Q24672061 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Establishment in culture of pluripotential cells from mouse embryos | Q27860625 | ||
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Embryonic Stem Cell Lines Derived from Human Blastocysts | Q27861010 | ||
| Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes | Q28209232 | ||
| Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
| Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle | Q28240311 | ||
| Reprogramming of human somatic cells to pluripotency with defined factors | Q28262710 | ||
| Chimerism of the Transplanted Heart | Q77452324 | ||
| Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts | Q77885470 | ||
| A Cre-loxP based system for studying horizontal gene transfer | Q80419816 | ||
| Isolation and expansion of adult cardiac stem cells from human and murine heart | Q80837204 | ||
| Cardiac stem cells in the real world | Q80842631 | ||
| Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice | Q81526279 | ||
| Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement | Q83043116 | ||
| Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction | Q83697673 | ||
| The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro | Q50684064 | ||
| Human cord blood CD133+ cells immunoselected by a clinical-grade apparatus differentiate in vitro into endothelial- and cardiomyocyte-like cells | Q50705076 | ||
| Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy | Q51371194 | ||
| Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart | Q51833240 | ||
| Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach | Q51996048 | ||
| Cardiac and Extracardiac Expression of Csx/Nkx2.5 Homeodomain Protein | Q52187531 | ||
| Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development | Q52200425 | ||
| Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. | Q53493162 | ||
| Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. | Q53518426 | ||
| Effects of bone marrow derived mesenchymal stem cells transplantation in acutely infarcting myocardium | Q53614409 | ||
| Cardiac progenitor cells in brown adipose tissue repaired damaged myocardium | Q54457409 | ||
| Bioenergetic and Functional Consequences of Bone Marrow-Derived Multipotent Progenitor Cell Transplantation in Hearts With Postinfarction Left Ventricular Remodeling | Q56777840 | ||
| Genetic Proof-of-Concept for Cardiac Gene Expression in Human Circulating Blood-Derived Progenitor Cells | Q58816187 | ||
| Notch Signaling Contributes to the Expression of Cardiac Markers in Human Circulating Progenitor Cells | Q58816239 | ||
| Cell-to-Cell Connection of Endothelial Progenitor Cells With Cardiac Myocytes by Nanotubes | Q58816268 | ||
| Differentiation of circulating endothelial progenitor cells to a cardiomyogenic phenotype depends on E-cadherin | Q58816270 | ||
| Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts | Q59064540 | ||
| Transdifferentiation of Blood-Derived Human Adult Endothelial Progenitor Cells Into Functionally Active Cardiomyocytes | Q60723059 | ||
| Isolation and characterization of bone marrow-derived mesenchymal progenitor cells with myogenic and neuronal properties | Q62704063 | ||
| Cardiomyocyte transplantation improves heart function | Q71476830 | ||
| Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants | Q72678188 | ||
| Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts | Q73791469 | ||
| Does transplantation of cardiomyocytes improve function of infarcted myocardium? | Q73914632 | ||
| Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization | Q77323614 | ||
| Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium | Q48944721 | ||
| Troponin I gene expression during human cardiac development and in end-stage heart failure | Q28268307 | ||
| Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages | Q28306800 | ||
| Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes | Q28345594 | ||
| Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair | Q28587325 | ||
| Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors | Q28588872 | ||
| GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm | Q28594534 | ||
| Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population | Q29616533 | ||
| Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
| Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts | Q29620480 | ||
| Autologous transplantation of bone marrow cells improves damaged heart function | Q30815113 | ||
| Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization | Q30876047 | ||
| Physiological Coupling of Donor and Host Cardiomyocytes After Cellular Transplantation | Q31141231 | ||
| Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation | Q33202256 | ||
| CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation | Q33216802 | ||
| Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells | Q33226565 | ||
| No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes | Q33235640 | ||
| Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo | Q33270812 | ||
| Bone marrow cells adopt the cardiomyogenic fate in vivo | Q33304156 | ||
| Lineage tracing of cardiac explant derived cells. | Q33328467 | ||
| Adult bone marrow-derived cells do not acquire functional attributes of cardiomyocytes when transplanted into peri-infarct myocardium | Q33330259 | ||
| Cardiomyocytes can be generated from marrow stromal cells in vitro | Q33843659 | ||
| Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages | Q33862841 | ||
| Myosin isoforms, muscle fiber types, and transitions | Q33918690 | ||
| Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function | Q33928468 | ||
| Skeletal actin mRNA increases in the human heart during ontogenic development and is the major isoform of control and failing adult hearts | Q34226034 | ||
| Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle | Q34361378 | ||
| Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts | Q34387398 | ||
| Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes. | Q34478174 | ||
| Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts | Q34508414 | ||
| The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling | Q34513743 | ||
| Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury | Q34657173 | ||
| Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy | Q35918432 | ||
| Human cardiac stem cells | Q35956924 | ||
| Human embryonic stem cell transplantation to repair the infarcted myocardium | Q36025653 | ||
| Antisera directed against connexin43 peptides react with a 43-kD protein localized to gap junctions in myocardium and other tissues | Q36220146 | ||
| Sequential activation of alpha-actin genes during avian cardiogenesis: vascular smooth muscle alpha-actin gene transcripts mark the onset of cardiomyocyte differentiation | Q36220944 | ||
| Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction | Q36349782 | ||
| The production and directed differentiation of human embryonic stem cells. | Q36376692 | ||
| A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential | Q36399846 | ||
| Plasticity and tissue regenerative potential of bone marrow-derived cells | Q36667445 | ||
| Concise review: stem cell antigen-1: expression, function, and enigma. | Q36767396 | ||
| Extra-atrial expression of the gene for atrial natriuretic factor. | Q37398504 | ||
| Hypoxia-inducible factor-2alpha transactivates Abcg2 and promotes cytoprotection in cardiac side population cells | Q38292474 | ||
| Transgenic enrichment of cardiomyocytes from human embryonic stem cells | Q40076187 | ||
| Identification and selection of cardiomyocytes during human embryonic stem cell differentiation | Q40145603 | ||
| Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. | Q40173892 | ||
| Niche-dependent translineage commitment of endothelial progenitor cells, not cell fusion in general, into myocardial lineage cells | Q40429287 | ||
| Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization | Q40641800 | ||
| Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells | Q40648427 | ||
| Cardiomyocyte differentiation of mouse and human embryonic stem cells | Q40729330 | ||
| Circulating endothelial precursors: mystery, reality, and promise | Q40741679 | ||
| Transplantation of bone marrow-derived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction | Q41829084 | ||
| Cardiomyocytes fuse with surrounding noncardiomyocytes and reenter the cell cycle | Q42916219 | ||
| Monoclonal antibodies to the muscle isoform of alpha-actinin--a marker for the study of the differentiation of skeletal and cardiac muscles | Q43611556 | ||
| Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects | Q43697103 | ||
| Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells | Q44145594 | ||
| TNF-alpha plus IFN-gamma induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses | Q44285411 | ||
| Cell fusion is the principal source of bone-marrow-derived hepatocytes | Q44383220 | ||
| Growth and differentiation of rat bone marrow stromal cells: does 5-azacytidine trigger their cardiomyogenic differentiation? | Q44448228 | ||
| Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation | Q44592644 | ||
| Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells | Q44680903 | ||
| Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells | Q45098355 | ||
| Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model | Q45218845 | ||
| The post-natal heart contains a myocardial stem cell population. | Q45855585 | ||
| Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection | Q45864313 | ||
| Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium? | Q45879469 | ||
| Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium | Q46057122 | ||
| Thymidine analogs are transferred from prelabeled donor to host cells in the central nervous system after transplantation: a word of caution | Q46864866 | ||
| Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats. | Q47575065 | ||
| Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart | Q47611450 | ||
| Evidence for circulating bone marrow-derived endothelial cells | Q47612637 | ||
| Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells | Q47820046 | ||
| Evidence for fusion between cardiac and skeletal muscle cells | Q47999205 | ||
| Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis | Q48132703 | ||
| Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. | Q48414650 | ||
| Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia | Q48460765 | ||
| Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction | Q48619654 | ||
| Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor. | Q48943611 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1058-1071 | |
| P577 | publication date | 2008-11-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Cardiogenic differentiation and transdifferentiation of progenitor cells | |
| P478 | volume | 103 |
| Q37715555 | 3-dimensional structures to enhance cell therapy and engineer contractile tissue. |
| Q38657237 | Acellular approaches for regenerative medicine: on the verge of clinical trials with extracellular membrane vesicles? |
| Q34413870 | Advanced material strategies for tissue engineering scaffolds |
| Q33957120 | Aesthetic cardiology: adipose-derived stem cells for myocardial repair |
| Q39376650 | Allogeneic cell therapy bioprocess economics and optimization: single-use cell expansion technologies |
| Q37310724 | Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. |
| Q33680007 | Assessment and optimization of cell engraftment after transplantation into the heart |
| Q36861582 | Bioengineered Myocardium Derived from Induced Pluripotent Stem Cells Improves Cardiac Function and Attenuates Cardiac Remodeling Following Chronic Myocardial Infarction in Rats |
| Q26852224 | Biomaterials to enhance stem cell function in the heart |
| Q46052779 | Bone morphogenetic protein-4 promotes induction of cardiomyocytes from human embryonic stem cells in serum-based embryoid body development |
| Q33742772 | CD117-positive cells of the heart: progenitor cells or mast cells? |
| Q34026068 | Calcification after myocardial infarction is independent of amniotic fluid stem cell injection |
| Q37248688 | Carbon nanotube-based substrates promote cardiogenesis in brown adipose-derived stem cells via β1-integrin-dependent TGF-β1 signaling pathway |
| Q33806910 | Cardiac aging in mice and humans: the role of mitochondrial oxidative stress |
| Q24615347 | Cardiac applications for human pluripotent stem cells |
| Q34588417 | Cardiac muscle regeneration: lessons from development |
| Q26772102 | Cardiac regeneration: epicardial mediated repair |
| Q37253735 | Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease |
| Q38175372 | Cardiac stem cell biology: glimpse of the past, present, and future. |
| Q38145165 | Cell shape and cardiosphere differentiation: a revelation by proteomic profiling. |
| Q27001159 | Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions |
| Q33618626 | Cell therapy for myocardial infarction. |
| Q51833044 | Cellular preservation therapy in acute myocardial infarction |
| Q38610604 | Concise Review: Mesenchymal Stem Cells in Cardiovascular Regeneration: Emerging Research Directions and Clinical Applications. |
| Q36807727 | Current Status and Perspectives in Stem Cell Therapy for Heart |
| Q35569536 | Derivation of functional ventricular cardiomyocytes using endogenous promoter sequence from murine embryonic stem cells |
| Q37789112 | Differential gene expressions in atrial and ventricular myocytes: insights into the road of applying embryonic stem cell-derived cardiomyocytes for future therapies |
| Q38000939 | Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells |
| Q39232292 | Differentiation of reprogrammed mouse cardiac fibroblasts into functional cardiomyocytes. |
| Q34181978 | Epicardium Formation as a Sensor in Toxicology |
| Q28551207 | Flexible Sheet-Type Sensor for Noninvasive Measurement of Cellular Oxygen Metabolism on a Culture Dish |
| Q35662315 | Functional Effect of Pim1 Depends upon Intracellular Localization in Human Cardiac Progenitor Cells. |
| Q34134245 | Generation and characterization of a transgenic pig carrying a DsRed-monomer reporter gene |
| Q37571651 | Ginsenoside Rg3 Improves Cardiac Function after Myocardial Ischemia/Reperfusion via Attenuating Apoptosis and Inflammation |
| Q47608058 | Histopathologic Assessment of Myocardial Regeneration |
| Q26774939 | How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart? |
| Q43765659 | Human umbilical cord perivascular cells exhibit enhanced cardiomyocyte reprogramming and cardiac function after experimental acute myocardial infarction. |
| Q39129176 | Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype |
| Q84858660 | Impact of synovial membrane-derived stem cell transplantation in a rat model of myocardial infarction |
| Q50532937 | In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells |
| Q37801268 | Induced pluripotent stem cells: developmental biology to regenerative medicine |
| Q27437615 | Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A |
| Q38560476 | Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges. |
| Q44958914 | Inhibition of p53 after acute myocardial infarction: reduction of apoptosis is counteracted by disturbed scar formation and cardiac rupture |
| Q39687224 | Intrinsic properties and external factors determine the differentiation bias of human embryonic stem cell lines |
| Q82981256 | Is bone marrow another target of diabetic complications? |
| Q33985922 | Local activation of cardiac stem cells for post‐myocardial infarction cardiac repair |
| Q33436706 | Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes |
| Q64106810 | Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention |
| Q33765470 | Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration |
| Q40312420 | Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells |
| Q42180872 | MicroRNA profiling predicts a variance in the proliferative potential of cardiac progenitor cells derived from neonatal and adult murine hearts |
| Q33112708 | MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells |
| Q37808269 | Molecular physiology of cardiac regeneration |
| Q33853829 | Myocardial regeneration: expanding the repertoire of thymosin β4 in the ischemic heart |
| Q38074105 | Natural ECM as biomaterial for scaffold based cardiac regeneration using adult bone marrow derived stem cells. |
| Q37783802 | New therapies for the failing heart: trans-genes versus trans-cells. |
| Q39044287 | Phenotypic assays for analyses of pluripotent stem cell-derived cardiomyocytes |
| Q39069601 | Possible Muscle Repair in the Human Cardiovascular System |
| Q34520935 | Present state and future perspectives of using pluripotent stem cells in toxicology research |
| Q26823933 | Programming and reprogramming a human heart cell |
| Q34544884 | Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activity |
| Q35005781 | Regulation of PTEN/Akt pathway enhances cardiomyogenesis and attenuates adverse left ventricular remodeling following thymosin β4 Overexpressing embryonic stem cell transplantation in the infarcted heart |
| Q37294044 | Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction |
| Q38037184 | Role of GATA-4 in Differentiation and Survival of Bone Marrow Mesenchymal Stem Cells |
| Q38220004 | Sca-1+ cardiac progenitor cells and heart-making: a critical synopsis. |
| Q30524835 | Secondary sphere formation enhances the functionality of cardiac progenitor cells |
| Q34441749 | Stem cell therapy and breast cancer treatment: review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment |
| Q37544884 | Stem cell therapy for cardiac repair: benefits and barriers |
| Q37651893 | Stem cell therapy for the heart: a perspective |
| Q28068007 | Strategies and Challenges to Myocardial Replacement Therapy |
| Q38719172 | Surface geometry of poly(ether imide) boosts mouse pluripotent stem cell spontaneous cardiomyogenesis via modulating the embryoid body formation process |
| Q42044067 | Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles. |
| Q34622172 | Targeted delivery of vascular endothelial growth factor improves stem cell therapy in a rat myocardial infarction model |
| Q37953831 | Therapeutic potential of intravenously administered human mesenchymal stromal cells |
| Q57821546 | Two mechanisms of cardiac stem cell-mediated cardiomyogenesis in the adult mammalian heart include formation of colonies and cell-in-cell structures |
| Q53278758 | mAb C19 targets a novel surface marker for the isolation of human cardiac progenitor cells from human heart tissue and differentiated hESCs |
| Q30981917 | miR-134 Modulates the Proliferation of Human Cardiomyocyte Progenitor Cells by Targeting Meis2. |
Search more.